Kendriya Vidyalayas enrolment at five-year low: Minister in Lok Sabha
New enrolments fell from 1.95 lakh in 2020-21 to 1.83 lakh in 2021-22, and 1.58 lakh in 2022-23. The number rose to 1.75 lakh in 2023-24, before falling to 1.39 lakh in 2024-25.
The total number of students studying in KVs has also dropped in this period, from nearly 13.88 lakh in 2020-21 to 13.5 lakh in 2024-25, says data provided by Education Minister Dharmendra Pradhan in response to a question from MPs BK Parthasarathi and Sudha R.
Kendriya Vidyalayas — a total of 1,280 are functioning in the country — cater to children of central government employees who are subject to transfers.
The drop in new enrolment comes even as the Centre approved the opening of 85 new KVs in December last year.
Pradhan said the Centre 'has approved opening of 85 new KVs under the civil/defence sector across the country and expansion of one existing KV — Shivamogga, Karnataka— by adding two additional sections in all the classes at an estimated amount of Rs. 5,872.08 crore'.
According to the data presented by Pradhan, the funds allocated to Kendriya Vidyalaya Sangathan (KVS) have seen a steady rise over the past year, increasing from Rs 6,437.68 crore in 2020-21 to Rs 8,727 crore in 2024-25.
Earlier this year, during meetings with States and Union Territories to discuss the performance, plan and budget under the PM-POSHAN (midday meal) scheme, the Ministry of Education had flagged a drop in government school enrolment at the primary and upper-primary levels across 23 States/UTs in 2024-25, and asked them to identify reasons for the drop and submit reports.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
an hour ago
- India Today
How Trump tariffs could impact Indian pharma's $8.7 bn dream run
For long, the high-value US market has driven the growth of the storied Indian generic drugs industry, where companies like Cipla, Sun Pharma and Dr Reddy's Laboratories, among others, have successfully challenged hundreds of off-patent drugs in the US and established a soaring business FY24, India exported $8.7 billion (Rs 76,113 crore) worth of pharma products to the US, which comprises over 11 per cent of India's total merchandise exports to that the same period, India exported $77.5 billion (Rs 6.8 lakh crore) worth of merchandise goods to the US and imported $42.2 billion (Rs 3.7 lakh crore) worth of goods from it, resulting in a trade surplus of $35.3 billion (Rs 3 lakh crore) in India's US is India's largest destination for pharma exports, accounting for over 31 per cent of the country's total pharmaceutical exports. As much as 47 per cent of all generics consumed in the US are imported from India. However, the Donald Trump administration's threat of imposition of a 25 per cent reciprocal tariff from August 1 (up from 0 to 6.7 per cent at present) has thrown the Indian pharma industry in a bind. Shares of Indian pharma companies, led by Sun Pharma, fell close to 6 per cent on the NSE (National Stock Exchange) on August 1 following president Trump's statements on the tariff imposition, and his letters to 17 top US pharma companies asking them to reduce their rates in line with what prevailed in other countries. Some fear Trump may send a similar letter to Sun Pharma, which earns as much as 20 per cent of its total revenues from the US Indian industry was hoping against hope that Trump would not hike tariffs on generic drugs since these are life-saving. However, Trump had indicated earlier this year too that tariffs on pharma products would be 25 per cent from April 2 onwards, without pinpointing any nation. He later gave a 90-day reprieve to countries, and the new deadline for the tariffs was put as August imports roughly $800 million worth of pharmaceutical products from the US, and imposes a tariff of 10 per cent. Experts say that even if higher tariffs are imposed on active pharma ingredients (APIs), which are raw materials going into pharma production, India could still be competitive, if tariffs on other API-supplying countries are higher than that of the US will still be dependent on countries like India since the cost of manufacturing certain drugs in the US would be at least six times compared to that of manufacturing the same product in India, say industry US market, which relies heavily on India for APIs and low-cost generics, would struggle to find alternatives, according to Namit Joshi, chairman of Pharmexcil (Pharmaceuticals Export Promotion Council of India). 'Efforts to shift pharmaceutical manufacturing and API production to other countries or within the US will take at least 3-5 years to establish meaningful capacity,' he was quoted in media reports. advertisement'There is no need for panic. The industry should lie low for now since the US has not yet increased the tariffs. Who else can give the US such competitively-priced goods in large quantities and high quality?' Daara Patel, secretary general of the Indian Drug Manufacturers Association, had said in an interview to INDIA TODAY in April. 'Even if it increases up to 10 per cent, the industry should be able to absorb it or pass it on to the US consumers. They would not mind paying for it since it all works on insurance money,' he what if the US decides to go for a higher tariff? 'In case the US raises tariffs beyond 15 per cent, India will have to look at newer markets in East Africa and the Middle East. These markets are neither high value nor high in volumes, but it will be a better option than dealing with an uncertain US market alone,' Patel had saidSubscribe to India Today Magazine- EndsTune InMust Watch
India Today
an hour ago
- India Today
Will Modi's new veshti strategy work down South?
(NOTE: This article was originally published in the India Today issue dated August 11, 2025)It was a sublimely choreographed moment of political theatre, of the grandiose genre that has long been seen to befit the man. Prime Minister Narendra Modi at the ancient Brihadiswara Temple, holding a vessel of gangajal from Kashi, framed against the gopuram and the blue Tamil skies behind. That July 27 image from Gangaikonda Chozhapuram, tweeted by BJP leader H. Raja with the caption 'Living Gangai Kondan', went viral. The symbolism was thick, and hard to two-day visit to Tamil Nadu, beginning July 26, also brought the usual rain of inaugurations: infrastructure projects worth Rs 4,800 crore, including the expansion of the VO Chidambaranar Port, and a Rs 450-crore terminal at the airport. CULTURAL MESSAGING If all that is a necessary part of the script in the BJP's push for the 2026 assembly election, it was the cultural spectacle and messaging that dominated the debates. Modi released a commemorative coin in honour of Rajendra Chola I, listened to Odhuvar recitations of Shaivite hymns, and attended a spiritual concert by Ilaiyaraaja. Flanked by heads of prominent Shaivaite mutts, he described the Chola empire as a 'blueprint for Viksit Bharat', praising its maritime influence and administrative acumen as early examples of Indian hailed the gesture as a reclamation of Tamil legacy. Critics, however, saw it as a calculated attempt to reinterpret Tamil history through a Hindutva prism. 'If Rajendra Chola was hailed as Gangai Kondan, it was because he defeated rulers of the Gangetic plains, not because he brought Ganga water,' says political commentator Priyan. 'The ASI's refusal to accept the antiquity of Keezhadi reflects the BJP's actual views.'Actor-politician Vijay weaponised the visit against both the BJP and the DMK, calling the saffron gestures 'political drama', but saying the DMK long ignored the Chola record, of course, reveals a handsome harvesting of history by the latter. As CM in 2010, M. Karunanidhi led the grand millennium gala at Brihadiswara Temple. In 2022, M.K. Stalin made a state event out of Raja Raja Chola's birth anniversary. 'Those late to Tamil pride are free to speak,' quips a DMK elder. 'History knows who lit the lamp first.'Senior journalist Thuglak Ramesh defended the BJP on the charge of being motivated by political gain. 'It may appear to be a strategy to counter the perception that the BJP is alien to Tamil identity. But I have heard the PM genuinely engages with Tamil antiquity. This goes beyond political calculation—it reflects a sincere personal devotion,' he says this is belied by the fact that the BJP strategy in Tamil Nadu mirrors its approach in other states and social demographies, appropriating local or community icons to build cultural bridges. He feels Tamil Nadu's unique polity—grounded in linguistic rights, social justice and federalism—would defy such subsumption. 'People appreciate such gestures, but they will still ask tough questions: about flood relief, education funding, archaeological flashpoints, the Governor. Symbolism alone won't suffice.' A people who have chosen to be ruled by regional parties since to India Today Magazine- EndsMust Watch
India.com
an hour ago
- India.com
Over 22 Crore Farmers Receive Rs 1.83 Lakh Crore Compensation Under PMFBY Since 2016
New Delhi: Since its launch in 2016, the Pradhan Mantri Fasal Bima Yojana (PMFBY) has insured 78.41 crore farmer applications up to June 30, 2025. During this period, around 22.67 crore farmers have received compensation amounting to Rs 1.83 lakh crore, highlighting the scheme's wide reach and impact in supporting farmers against crop loss, informed Ramnath Thakur, Minister of State for Agriculture and Farmers Welfare in a written reply to Rajya Sabha on August 1. Pradhan Mantri Fasal Bima Yojana on February 18, 2025 , completed nine years of its launch. Launched in 2016 by Prime Minister Narendra Modi, the scheme provides a comprehensive shield against crop losses caused by unforeseen natural hazards. This protection not only stabilises farmers' income but also encourages them to adopt new practices. Crop insurance is an important risk mitigation measure to protect farmers from natural calamities. Its purpose is to provide financial assistance to farmers suffering from crop loss/damage due to natural calamities such as hailstorm , drought , flood , cyclone , heavy and unseasonal rains , disease and pest attacks etc. MoS further apprised the house about the steps undertaken by the government to strengthen implementation of this scheme, according to Ministry of Agriculture & Farmers Welfare. Among the various steps, development of National Crop Insurance Portal (NCIP) as a single source of data ensuring subsidy payment, co-ordination, transparency, dissemination of information and delivery of services including direct online enrolment of farmers, uploading/obtaining individual insured famer's details for better monitoring and to ensure transfer of claim amount electronically to the individual farmer's Bank Account. In order to rigorously monitor claim disbursal process, a dedicated module namely 'Digiclaim Module' has been operationalized for payment of claims from Kharif 2022 onwards. It involves integration of National Crop Insurance Portal (NCIP) with Public Finance Management System (PFMS) and accounting system of Insurance Companies. Delinking of Central Government share of premium subsidy from that of State Governments has been implemented so that farmers can get proportionate claims relating to the Central Government share. Opening of ESCROW Account by the State Government concerned for deposit of their premium share in advance as per provisions of the scheme has been made mandatory w.e.f. Kharif 2025 season. Also, towards leveraging technology in implementation of the scheme, various steps like capturing of yield data/Crop Cutting Experiments (CCEs) data through CCE-Agri App & uploading it on the NCIP, allowing insurance companies to witness the conduct of CCEs, integration of State land records with NCIP etc. have already been taken to improve timely settlement of the claims to farmers. Provision of 12 per cent penalty on delay in payment of claims by insurance company is auto calculated on National Crop Insurance Portal (NCIP). MoS said that both Public Sector and Private Insurance Companies have been involved to increase the coverage of farmers especially non-loanee farmers and to bring more competition in crop insurance sector so as to provide the best services to farmers at competitive rates. Due to increased competition, actuarial/bidded premium rates have also decreased. As compared to erstwhile crop insurance schemes, coverage of farmer applications has increased from 371 lakhs in 2014-15 to 1510 lakhs in 2024-25. He added that the number of non-loanee farmer applications has also increased from 20 lakhs in 2014-15 to 522 lakhs in 2024-25.
